| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 42 |
| 1 | DENOSUMAB | 38 |
| 2 | METHOTREXATE | 38 |
| 3 | ADALIMUMAB | 23 |
| 4 | CELECOXIB | 21 |
| 5 | IBUPROFEN | 21 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 20 |
| 7 | IBUPFROFEN | 20 |
| 8 | IBUPROFEN 200 MG | 20 |
| 9 | IBUPROFEN 200MG | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOCILIZUMAB-AAZG | 15 | 0.0244 |
| 1 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 2 | ACETIC ACID | 1 | 0.0028 |
| 3 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 4 | VALERIAN | 1 | 0.0014 |
| 5 | 12%AZELAIC ACID | 1 | 0.0012 |
| 6 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 7 | AZELAIC ACID | 1 | 0.0010 |
| 8 | TERBINAFINE TABLETS 250 MG | 1 | 0.0008 |
| 9 | HALOBETASOL PROPIONATE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 38 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 2 | RANK Ligand Inhibitor [EPC] | 38 |
| 3 | Corticosteroid [EPC] | 26 |
| 4 | Proton Pump Inhibitor [EPC] | 26 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 16 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| 7 | Vitamin C [EPC] | 13 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 9 | Calcium [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Allylamine Antifungal [EPC] | 3 | 0.0004 |
| 1 | Recombinant Human Growth Hormone [EPC] | 9 | 0.0004 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 5 | Antiparasitic [EPC] | 1 | 0.0002 |
| 6 | Pediculicide [EPC] | 1 | 0.0002 |
| 7 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 8 | RANK Ligand Inhibitor [EPC] | 38 | 0.0002 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |